Sean Brynjelsen

Insider Reports History

Entity
Individual
Location
C/O Eton Pharmaceuticals, Inc., 21925 W Field Pkwy #235, Deer Park, IL
Signature
/s/ James R. Gruber
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sean Brynjelsen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eton Pharmaceuticals, Inc. President & CEO, Director Stock Option (Right to buy) 2.47M Feb 13, 2024 Direct

Insider Reports Filed by Sean Brynjelsen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ETON Eton Pharmaceuticals, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 President & CEO, Director
ETON Eton Pharmaceuticals, Inc. Mar 3, 2023 1 $0 4 Mar 3, 2023 President & CEO, Director
ETON Eton Pharmaceuticals, Inc. Sep 22, 2022 1 $21K 4 Sep 23, 2022 Chief Executive Officer, Director
ETON Eton Pharmaceuticals, Inc. Jul 12, 2022 1 $0 4 Jul 18, 2022 Chief Executive Officer
ETON Eton Pharmaceuticals, Inc. Feb 7, 2022 1 $0 4 Feb 28, 2022 President & CEO, Director
ETON Eton Pharmaceuticals, Inc. Aug 20, 2021 1 $43.2K 4 Aug 20, 2021 President & CEO, Director
ETON Eton Pharmaceuticals, Inc. Jun 3, 2021 1 $29.8K 4 Jun 3, 2021 President & CEO, Director